{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:07:29Z","timestamp":1784747249174,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate temporal changes in breast cancer lifetime risk (BC-LTR) over a 10-year period among women with clinically elevated risk but without known pathogenic genetic mutations, using the International Breast Cancer Intervention Study (IBIS) breast cancer risk evaluation tool, and to assess implications for personalised surveillance strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>In this retrospective study, women referred for elevated risk assessment in 2014 underwent BC-LTR estimation using IBIS (v8.0b). Risk was recalculated in 2024 using the same model without recalibration. Women who developed breast cancer, underwent bilateral mastectomy, died during follow-up, were older than 85 years in 2024, or carried pathogenic genetic mutations were excluded, as IBIS BC-LTR recalculation is not applicable in these contexts. Risk factor temporal changes were evaluated using paired statistics. A linear mixed model assessed predictors of IBIS BC-LTR and their association with temporal changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 362 eligible women, mean IBIS BC-LTR decreased from 23% in 2014 to 19% in 2024 (mean absolute change\u2009=\u20096.5,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Risk group reclassification occurred in 44%: 36% shifted to a lower risk category and 8% to a higher category. Increase in IBIS BC-LTR was associated with increasing density (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001), higher BMI (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002), current HRT use (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007), and additional affected relatives (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.03), whereas downward reclassification was mainly linked to decreasing density (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IBIS BC-LTR estimates change over time in women with elevated clinical risk. Periodic reassessment may better align estimated risk with tailored screening strategies, supporting more precise, individualised surveillance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Critical relevance statement<\/jats:title>\n                    <jats:p>Variation in IBIS BC-LTR scores over time highlights the need for periodic recalculation to improve individual risk stratification and guide more appropriate, personalised imaging and screening pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Breast cancer risk models identify women most likely to benefit from supplemental screening.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>IBIS BC-LTR estimates changed over 10 years, reclassifying over 40% of women with elevated baseline risk into a different risk category. Periodic IBIS BC-LTR recalculation is essential to optimise risk stratification and screening pathways.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13244-026-02355-9","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:28:06Z","timestamp":1784744886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temporal changes in breast cancer lifetime risk and implications for personalised surveillance in high-risk women"],"prefix":"10.1186","volume":"17","author":[{"given":"Machteld","family":"Keupers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Nijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Sarkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Kuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Cockmartin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Wildiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Bosmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Van Ongeval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"2355_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.breast.2022.09.007","volume":"66","author":"FTH Bodewes","year":"2022","unstructured":"Bodewes FTH, van Asselt AA, Dorrius MD, Greuter MJW, de Bock GH (2022) Mammographic breast density and the risk of breast cancer: a systematic review and meta-analysis. Breast 66:62\u201368. https:\/\/doi.org\/10.1016\/j.breast.2022.09.007","journal-title":"Breast"},{"key":"2355_CR2","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/sim.1668","volume":"23","author":"J Tyrer","year":"2004","unstructured":"Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23:1111\u20131130. https:\/\/doi.org\/10.1002\/sim.1668","journal-title":"Stat Med"},{"key":"2355_CR3","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1007\/s00330-022-08617-6","volume":"32","author":"RM Mann","year":"2022","unstructured":"Mann RM, Athanasiou A, Baltzer PAT et al (2022) Breast cancer screening in women with extremely dense breasts: recommendations of the European Society of Breast Imaging (EUSOBI). Eur Radiol 32:4036\u20134045. https:\/\/doi.org\/10.1007\/s00330-022-08617-6","journal-title":"Eur Radiol"},{"key":"2355_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13244-020-00905-3","volume":"11","author":"RM Trimboli","year":"2020","unstructured":"Trimboli RM, Giorgi Rossi P, Battisti NML et al (2020) Do we still need breast cancer screening in the era of targeted therapies and precision medicine? Insights Imaging 11:105. https:\/\/doi.org\/10.1186\/s13244-020-00905-3","journal-title":"Insights Imaging"},{"key":"2355_CR5","unstructured":"Centrum voor Kankeropsporing (2022) JAAR Rapport Bevolkingsonderzoek Borstkanker 2022 Available via JAAR. https:\/\/dikkedarmkanker.bevolkingsonderzoek.be\/sites\/default\/files\/2022-12\/Jaarrapport%202022_0.pdf. Accessed 4 Jun 2026"},{"key":"2355_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9873954","volume":"2020","author":"B Dullens","year":"2020","unstructured":"Dullens B, de Putter R, Lambertini M et al (2020) Cancer surveillance in healthy carriers of germline pathogenic variants in BRCA1\/2: a review of secondary prevention guidelines. J Oncol 2020:1\u201313. https:\/\/doi.org\/10.1155\/2020\/9873954","journal-title":"J Oncol"},{"key":"2355_CR7","unstructured":"Belgian Society of Human Genetics (2022) HBOC management guidelines. Available via BSHG. https:\/\/www.college-genetics.be\/assets\/recommendations\/fr\/guidelines\/HBOC%20management%20guidelines.pdf. Accessed 4 Jun 2026"},{"key":"2355_CR8","doi-asserted-by":"publisher","first-page":"6348","DOI":"10.1007\/s00330-024-10740-5","volume":"34","author":"M Marcon","year":"2024","unstructured":"Marcon M, Fuchsj\u00e4ger MH, Clauser P, Mann RM (2024) ESR essentials: screening for breast cancer\u2014general recommendations by EUSOBI. Eur Radiol 34:6348\u20136357. https:\/\/doi.org\/10.1007\/s00330-024-10740-5","journal-title":"Eur Radiol"},{"key":"2355_CR9","unstructured":"Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (RIZIV\/INAMI) KB (2003) Formulier bijlage 86: notificatie sterk verhoogd risico risico op borstkanker. Available via RIZIV. https:\/\/www.riziv.fgov.be\/nl\/professionals\/individuele-zorgverleners\/artsen\/formulieren-voor-de-artsen. Accessed 4 Jun 2026"},{"key":"2355_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10549-017-4247-z","volume":"164","author":"JA Cintolo-Gonzalez","year":"2017","unstructured":"Cintolo-Gonzalez JA, Braun D, Blackford AL et al (2017) Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications. Breast Cancer Res Treat 164:263\u2013284. https:\/\/doi.org\/10.1007\/s10549-017-4247-z","journal-title":"Breast Cancer Res Treat"},{"key":"2355_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10549-011-1818-2","volume":"132","author":"C Meads","year":"2012","unstructured":"Meads C, Ahmed I, Riley RD (2012) A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance. Breast Cancer Res Treat 132:365\u2013377. https:\/\/doi.org\/10.1007\/s10549-011-1818-2","journal-title":"Breast Cancer Res Treat"},{"key":"2355_CR12","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S1470-2045(18)30902-1","volume":"20","author":"MB Terry","year":"2019","unstructured":"Terry MB, Liao Y, Whittemore AS et al (2019) 10-year performance of four models of breast cancer risk: a validation study. Lancet Oncol 20:504\u2013517. https:\/\/doi.org\/10.1016\/S1470-2045(18)30902-1","journal-title":"Lancet Oncol"},{"key":"2355_CR13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41571-020-0388-9","volume":"17","author":"N Pashayan","year":"2020","unstructured":"Pashayan N, Antoniou AC, Ivanus U et al (2020) Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol 17:687\u2013705. https:\/\/doi.org\/10.1038\/s41571-020-0388-9","journal-title":"Nat Rev Clin Oncol"},{"key":"2355_CR14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/jmg.40.11.807","volume":"40","author":"E Amir","year":"2003","unstructured":"Amir E, Evans DG, Shenton A et al (2003) Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40:807\u2013814. https:\/\/doi.org\/10.1136\/jmg.40.11.807","journal-title":"J Med Genet"},{"key":"2355_CR15","doi-asserted-by":"publisher","first-page":"100820","DOI":"10.1016\/j.gim.2023.100820","volume":"25","author":"JD Brooks","year":"2023","unstructured":"Brooks JD, Mah A, Christensen RAG, Arneja J, Eisen A, Chiarelli AM (2023) Validation of the International Breast Cancer Intervention Study (IBIS) model in the high risk ontario breast screening program: a retrospective cohort study. Genet Med 25:100820. https:\/\/doi.org\/10.1016\/j.gim.2023.100820","journal-title":"Genet Med"},{"key":"2355_CR16","doi-asserted-by":"publisher","first-page":"111540","DOI":"10.1016\/j.ejrad.2024.111540","volume":"177","author":"M Keupers","year":"2024","unstructured":"Keupers M, Woussen S, Postema S et al (2024) Limited impact of adding digital breast tomosynthesis to full field digital mammography in an elevated breast cancer risk population. Eur J Radiol 177:111540. https:\/\/doi.org\/10.1016\/j.ejrad.2024.111540","journal-title":"Eur J Radiol"},{"key":"2355_CR17","unstructured":"D\u2019Orsi CJ, Sickles EA, Mendelson EB, Morris EA et al (2013) ACR BI-RADS atlas: breast imaging reporting and data system, 5th edn. American College of Radiology, Reston"},{"key":"2355_CR18","doi-asserted-by":"publisher","first-page":"ITC97","DOI":"10.7326\/AITC202107200","volume":"174","author":"MA McNeil","year":"2021","unstructured":"McNeil MA, Merriam SB (2021) Menopause. Ann Intern Med 174:ITC97\u2013ITC112. https:\/\/doi.org\/10.7326\/AITC202107200","journal-title":"Ann Intern Med"},{"key":"2355_CR19","unstructured":"Belgian Society of Human Genetics (2019) HBOC testing criteria. Available via BSHG. https:\/\/www.college-genetics.be\/assets\/recommendations\/fr\/guidelines\/HBOC%20testing%20criteria%20-%202019.pdf. Accessed 4 Jun 2026"},{"key":"2355_CR20","doi-asserted-by":"publisher","first-page":"e14836","DOI":"10.7717\/peerj.14836","volume":"11","author":"A Ohmaru","year":"2023","unstructured":"Ohmaru A, Maeda K, Ono H et al (2023) Age-related change in mammographic breast density of women without history of breast cancer over a 10-year retrospective study. PeerJ 11:e14836. https:\/\/doi.org\/10.7717\/peerj.14836","journal-title":"PeerJ"},{"key":"2355_CR21","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Est\u00e9vez L, Cort\u00e9s J, P\u00e9rez S, Calvo I, Gallegos I, Moreno-Bueno G (2021) Obesity and breast cancer: a paradoxical and controversial relationship influenced by menopausal status. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.705911.","DOI":"10.3389\/fonc.2021.705911"},{"key":"2355_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12847-w","volume":"24","author":"C Kelley-Jones","year":"2024","unstructured":"Kelley-Jones C, Scott SE, Waller J (2024) Acceptability of de-intensified screening for women at low risk of breast cancer: a randomised online experimental survey. BMC Cancer 24:1111. https:\/\/doi.org\/10.1186\/s12885-024-12847-w","journal-title":"BMC Cancer"},{"key":"2355_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12083-2","volume":"24","author":"LH Loft","year":"2024","unstructured":"Loft LH, Pedersen LH, Bigaard J, Bojesen SE (2024) Attitudes towards risk-stratified breast cancer screening: a population-based survey among 5,001 Danish women. BMC Cancer 24:347. https:\/\/doi.org\/10.1186\/s12885-024-12083-2","journal-title":"BMC Cancer"},{"key":"2355_CR24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1148\/radiol.2019190872","volume":"294","author":"K Dembrower","year":"2020","unstructured":"Dembrower K, Liu Y, Azizpour H et al (2020) Comparison of a deep learning risk score and standard mammographic density score for breast cancer risk prediction. Radiology 294:265\u2013272. https:\/\/doi.org\/10.1148\/radiol.2019190872","journal-title":"Radiology"},{"key":"2355_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1148\/radiol.2020201620","volume":"297","author":"M Eriksson","year":"2020","unstructured":"Eriksson M, Czene K, Strand F et al (2020) Identification of women at high risk of breast cancer who need supplemental screening. Radiology 297:327\u2013333. https:\/\/doi.org\/10.1148\/radiol.2020201620","journal-title":"Radiology"},{"key":"2355_CR26","doi-asserted-by":"publisher","unstructured":"Wang Y-K, Klanecek Z, Wagner T et al (2025) Using explainable AI to characterize features in the Mirai mammographic breast cancer risk prediction model. Radiol Artif Intell. https:\/\/doi.org\/10.1148\/ryai.240417","DOI":"10.1148\/ryai.240417"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02355-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-026-02355-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02355-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:28:07Z","timestamp":1784744887000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13244-026-02355-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2355"],"URL":"https:\/\/doi.org\/10.1186\/s13244-026-02355-9","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University Hospital Leuven under OBC reference number S69370. The requirement for informed consent was waived because of the retrospective nature of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"191"}}